Press Releases
Press releases found on our website are intended as reference information for investors and journalists. The information contained in each press release was accurate at the time of issuance and caprotec™ bioanalytics GmbH assumes no responsibility for updating the information to reflect subsequent developments.
caprotec bioanalytics Announces Further Patent Protection OF Its CCMS Technology
Berlin, Germany, February 8, 2012 - caprotec bioanalytics GmbH announced today the issuance of patents in the US, Japan, Canada, Australia and Israel related to methods and composition of matter of its proprietary Capture Compound Mass Spectrometry (CCMS) technology.
Download
caprotec bioanalytics Discovers Novel Drug-Protein Interactions of Three Anti-Cancer Drugs Using CCMS Technology
Berlin, Germany and Burlington, MA, December 8, 2011 - caprotec bioanalytics GmbH announced today the discovery of previously unknown specific drug-protein interactions for several anti-cancer drugs and the identification of potential novel co-targets of the drug molecules through the use of company's CCMS technology. These scientific findings are published in peer-reviewed articles in Journal of Proteomics, Proteomics and Journal of Biomedicine and Biotechnology.
Download
caprotec bioanalytics Announces Collaborative Research Agreement With Bayer CropScience
Berlin, Germany and Burlington, MA, December 6, 2011 - caprotec bioanalytics GmbH announced today that it has initiated a research collaboration with Bayer CropScience. Under the collaborative research agreement, caprotec will use its proprietary CCMS (Capture Compound Mass Spectrometry) technology to profile the interactions of one of Bayer CropScience's undisclosed new active ingredients in the relevant biological system.
Download
caprotec bioanalytics GmbH Appoints Marc Voigt as Managing Director, Chief Financial Officer and Chief Operating Officer
Berlin, Germany and Burlington, MA, July 12, 2011 - caprotec bioanalytics GmbH announced today the appointment of Marc Voigt as Managing Director, Chief Financial Officer and Chief Operating Officer.
Download
caprotec bioanalytics Increases Series B Financing in Second Closing to Euro 5 Million
Berlin, Germany and Burlington, MA, May 9, 2011 - caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform technology for analyzing small molecule – protein
interactions, today announced a second closing of Euro 1 million to its Series B funding, bringing the total for the round to Euro 5 million in equity. The capital increase was fully subscribed by LBBW
Venture Capital GmbH, Stuttgart, joining existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-known private investors.
Download
caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology
Berlin, Germany and Burlington, MA, February 28, 2011 - caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology.
Download
caprotec bioanalytics GmbH Appoints Prof. Dr. Rainer Metternich as Managing Director, Chief Officer and Chief Operating Officer
Berlin, Germany and Burlington, MA, October 4, 2010 - caprotec bioanalytics GmbH announced today the appointment of Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer of the company. Prior joining caprotec, Prof. Metternich held senior leadership positions at Merck & Co., Schering AG and Novartis.
Download
caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ For Applications in Functional Proteomics and Drug Development
Berlin, Germany and Burlington, MA, Sepember 30, 2010 - caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits™, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.
Download
caprotec bioanalytics announces the successful completion of a collaborative research project with Roche
Berlin, Germany and Burlington, MA, June 28, 2010 - caprotec bioanalytics GmbH announced today that it has succesfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding characteristics and interaction of one undisclosed drug candidate with its human target proteins.
Download
caprotec bioanalytics Completes Series B Financing Round of EUR 4 Million
Berlin, Germany and Burlington, MA, May 13, 2010 - caprotec bioanalytics GmbH today announced the closing of a EUR 4 million ($5.1M) Series B Financing Round with existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-known private investors. The proceeds will enable further development and marketing of the Company´s proprietary CCMS (Capture Compound Mass Spectrometry) platform technology for analyzing complex protein mixtures.
Download
caprotec bioanalytics Announces Commercial Launch Of Three New caproKits™ For Applications In Proteomics And Drug Development
Berlin, Germany and Burlington, MA, January 26, 2010 - caprotec bioanalytics GmbH anounced today the commercial launch of three new caporKits™, enabling the discovery, identification and characterization of proteins belonging to the group of metallo-proteases, histon-deacetylases and GDP/GTP binding proteins.
Download
Germany-based caprotec bioanalytics opens US Subsidiary in Burlington, Massachusetts; Appoints President
Burlington, MA, and Berlin, Germany, November 19, 2009 - caprotec bioanalytics GmbH ammounced today the opening of its US subsidiary based in Burlington, MA. caprotec Inc. will be responsible for North American sales, marketing and support of caprotec´s proprietary Capture Compound Mass Spectrometry (CCMS) technology and its related products.
Download
caprotec bioanalytics announces launch of new Stauro caproKit™ for signal transduction research and drug development
Berlin, Germany, May 13, 2009 - caprotec bioanalytics GmbH announced today the commercial launch of its Stauro caproKit™, enabling the discovery, identification and characterization of proteins interacting with staurosporine.
Download
caprotec bioanalytics announces the appointment of Funakoshi as distributor for its products on the Japanese market
Berlin, Germany, February 09, 2009 - caprotec bioanalytics GmbH announced today that they entered into an exclusive distributorship agreement with Funakoshi Co. Ltd. for the marketing and sales of caprotec´s research products in the country of Japan.
Download
caprotec bioanalytics announces launch of new products for research and drug development
Berlin, Germany, January 19, 2009 - caprotec bioanalytics GmbH announced today that they completed the commercial launch of their first two caproKits™.
Download
caprotec bioanalytics awarded 0,6 m € grant for research and development
Berlin, Germany, December 15, 2008 – caprotec bioanalytics GmbH announced today that they won a grant of up to 0,6 m € over a period of 2 years.
Download
caprotec bioanalytics adds two patents to its significant patent estate
Berlin, Germany, December 2, 2008 – caprotec bioanalytics GmbH announced today that the Canadian Patent Office hase granted two Canadian patents covering the company's revolutionary Capture Compound Mass Spectrometry (CCMS) technology.
Download
caprotec bioanalytics and Merck KGaA Sign Collaboration Agreement
Berlin, Germany, May 28, 2008 – caprotec bioanalytics GmbH announced today that they have signed a collaboration agreement with Merck KGaA acting for its division Merck Serono.
Download
caprotec bioanalytics GmbH Appoints Dr. Mathias Grote as Chief Financial and Chief Operating Officer
Berlin, Germany, March 13, 2008 – caprotec bioanalytics GmbH announced today the appointment of Dr. Mathias Grote as Chief Financial Officer and Chief Operating Officer of the Company.
Download
Life Science Startup caprotec bioanalytics Receives Additional Venture Capital Funding
Berlin, Germany, January 10, 2008 – caprotec bioanalytics GmbH receives a total of EUR 6 million ($8.8M) in two rounds of financing.
Download
caprotec bioanalytics obtains € 4.5M (ca. $6.5M) Startup financing
Berlin, Germany, November 22, 2007 – caprotec bioanalytics GmbH has obtained capital investments.
Download
